Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment

Recruiting N/A Interventional Study
Esophageal Cancer Gastric Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
2,200 (estimated)
Sponsor
KU Leuven · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer. The main question it aims to answer are: * Which diagnostic modality is preferred by patients and the general population? * Which features of the diagnostic test are most detrimental in the decision-making for one or the other modality? * …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Individuals \>18yo to 75yo (upper age limit of Barrett's surveillance) 2. Access to computer or smartphone 3. Clear understanding of available languages of the experiment (English, French, Dutch, Spanish, German, Chinese, Japanese) Exclusion Criteria: 1. Individuals less th…
Contacts

Stijn Vanstraelen, MD

16346822

stijn.vanstraelen@kuleuven.be

CONTACT